{"title":"非典型 G 蛋白信号","authors":"Bernd Nürnberg , Sandra Beer-Hammer , Ellen Reisinger , Veronika Leiss","doi":"10.1016/j.pharmthera.2024.108589","DOIUrl":null,"url":null,"abstract":"<div><p>The original paradigm of classical - also referred to as canonical - cellular signal transduction of heterotrimeric G proteins (G protein) is defined by a hierarchical, orthograde interaction of three players: the agonist-activated G protein-coupled receptor (GPCR), which activates the transducing G protein, that in turn regulates its intracellular effectors. This receptor-transducer-effector concept was extended by the identification of regulators and adapters such as the regulators of G protein signaling (RGS), receptor kinases like βARK, or GPCR-interacting arrestin adapters that are integrated into this canonical signaling process at different levels to enable fine-tuning. Finally, the identification of atypical signaling mechanisms of classical regulators, together with the discovery of novel modulators, added a new and fascinating dimension to the cellular G protein signal transduction. This heterogeneous group of accessory G protein modulators was coined “activators of G protein signaling” (AGS) proteins and plays distinct roles in canonical and non-canonical G protein signaling pathways. AGS proteins contribute to the control of essential cellular functions such as cell development and division, intracellular transport processes, secretion, autophagy or cell movements. As such, they are involved in numerous biological processes that are crucial for diseases, like diabetes mellitus, cancer, and stroke, which represent major health burdens. Although the identification of a large number of non-canonical G protein signaling pathways has broadened the spectrum of this cellular communication system, their underlying mechanisms, functions, and biological effects are poorly understood. In this review, we highlight and discuss atypical G protein-dependent signaling mechanisms with a focus on inhibitory G proteins (G<sub>i</sub>) involved in canonical and non-canonical signal transduction, review recent developments and open questions, address the potential of new approaches for targeted pharmacological interventions.</p></div>","PeriodicalId":402,"journal":{"name":"Pharmacology & Therapeutics","volume":"255 ","pages":"Article 108589"},"PeriodicalIF":12.0000,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0163725824000093/pdfft?md5=bc5565dedabd2dfbc5d23d1729365c86&pid=1-s2.0-S0163725824000093-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Non-canonical G protein signaling\",\"authors\":\"Bernd Nürnberg , Sandra Beer-Hammer , Ellen Reisinger , Veronika Leiss\",\"doi\":\"10.1016/j.pharmthera.2024.108589\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The original paradigm of classical - also referred to as canonical - cellular signal transduction of heterotrimeric G proteins (G protein) is defined by a hierarchical, orthograde interaction of three players: the agonist-activated G protein-coupled receptor (GPCR), which activates the transducing G protein, that in turn regulates its intracellular effectors. This receptor-transducer-effector concept was extended by the identification of regulators and adapters such as the regulators of G protein signaling (RGS), receptor kinases like βARK, or GPCR-interacting arrestin adapters that are integrated into this canonical signaling process at different levels to enable fine-tuning. Finally, the identification of atypical signaling mechanisms of classical regulators, together with the discovery of novel modulators, added a new and fascinating dimension to the cellular G protein signal transduction. This heterogeneous group of accessory G protein modulators was coined “activators of G protein signaling” (AGS) proteins and plays distinct roles in canonical and non-canonical G protein signaling pathways. AGS proteins contribute to the control of essential cellular functions such as cell development and division, intracellular transport processes, secretion, autophagy or cell movements. As such, they are involved in numerous biological processes that are crucial for diseases, like diabetes mellitus, cancer, and stroke, which represent major health burdens. Although the identification of a large number of non-canonical G protein signaling pathways has broadened the spectrum of this cellular communication system, their underlying mechanisms, functions, and biological effects are poorly understood. In this review, we highlight and discuss atypical G protein-dependent signaling mechanisms with a focus on inhibitory G proteins (G<sub>i</sub>) involved in canonical and non-canonical signal transduction, review recent developments and open questions, address the potential of new approaches for targeted pharmacological interventions.</p></div>\",\"PeriodicalId\":402,\"journal\":{\"name\":\"Pharmacology & Therapeutics\",\"volume\":\"255 \",\"pages\":\"Article 108589\"},\"PeriodicalIF\":12.0000,\"publicationDate\":\"2024-01-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0163725824000093/pdfft?md5=bc5565dedabd2dfbc5d23d1729365c86&pid=1-s2.0-S0163725824000093-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacology & Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0163725824000093\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0163725824000093","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
摘要
异三聚体 G 蛋白(G 蛋白)经典--也称为规范--细胞信号传导的最初范式是由三个角色的分层正交相互作用定义的:激动剂激活的 G 蛋白偶联受体(GPCR)激活传导 G 蛋白,G 蛋白反过来调节其细胞内效应器。这种受体-传导因子-效应因子的概念通过识别调节因子和适配器(如 G 蛋白信号转导调节因子(RGS)、βARK 等受体激酶或与 GPCR 相互作用的停滞蛋白适配器)得到了扩展,这些调节因子和适配器在不同水平上被整合到这一典型的信号转导过程中,以实现微调。最后,经典调控因子的非典型信号转导机制以及新型调节剂的发现,为细胞 G 蛋白信号转导增添了一个新的迷人维度。这组异质的附属 G 蛋白调节剂被称为 "G 蛋白信号转导激活剂"(AGS)蛋白,它们在规范和非规范 G 蛋白信号转导途径中发挥着不同的作用。AGS 蛋白有助于控制细胞的基本功能,如细胞发育和分裂、细胞内转运过程、分泌、自噬或细胞运动。因此,它们参与了许多对糖尿病、癌症和中风等疾病至关重要的生物过程,而这些疾病是主要的健康负担。尽管大量非经典 G 蛋白信号通路的发现拓宽了这一细胞通讯系统的范围,但人们对它们的内在机制、功能和生物效应还知之甚少。在这篇综述中,我们将重点介绍和讨论非典型 G 蛋白依赖性信号转导机制,重点是参与规范和非规范信号转导的抑制性 G 蛋白(Gi),回顾最新进展和未决问题,探讨有针对性的药物干预新方法的潜力。
The original paradigm of classical - also referred to as canonical - cellular signal transduction of heterotrimeric G proteins (G protein) is defined by a hierarchical, orthograde interaction of three players: the agonist-activated G protein-coupled receptor (GPCR), which activates the transducing G protein, that in turn regulates its intracellular effectors. This receptor-transducer-effector concept was extended by the identification of regulators and adapters such as the regulators of G protein signaling (RGS), receptor kinases like βARK, or GPCR-interacting arrestin adapters that are integrated into this canonical signaling process at different levels to enable fine-tuning. Finally, the identification of atypical signaling mechanisms of classical regulators, together with the discovery of novel modulators, added a new and fascinating dimension to the cellular G protein signal transduction. This heterogeneous group of accessory G protein modulators was coined “activators of G protein signaling” (AGS) proteins and plays distinct roles in canonical and non-canonical G protein signaling pathways. AGS proteins contribute to the control of essential cellular functions such as cell development and division, intracellular transport processes, secretion, autophagy or cell movements. As such, they are involved in numerous biological processes that are crucial for diseases, like diabetes mellitus, cancer, and stroke, which represent major health burdens. Although the identification of a large number of non-canonical G protein signaling pathways has broadened the spectrum of this cellular communication system, their underlying mechanisms, functions, and biological effects are poorly understood. In this review, we highlight and discuss atypical G protein-dependent signaling mechanisms with a focus on inhibitory G proteins (Gi) involved in canonical and non-canonical signal transduction, review recent developments and open questions, address the potential of new approaches for targeted pharmacological interventions.
期刊介绍:
Pharmacology & Therapeutics, in its 20th year, delivers lucid, critical, and authoritative reviews on current pharmacological topics.Articles, commissioned by the editor, follow specific author instructions.This journal maintains its scientific excellence and ranks among the top 10 most cited journals in pharmacology.